semaglutide and cirrhosis Can be used in patients with liver cirrhosis, if so, what dosing and monitoring are recommended for compensated versus decompensated disease? Semaglutide's Efficacy in Phase 3

For insulin-resistant patients, this dual actionappetite reduction plus metabolic improvementaddresses the root problem rather than forcing the body to fight against its own hormonal imbalance

Each persons dose and treatment plan is tailored to their individual needs

retail pharmacies reached 2.6 million by Dec 2023 ( [1] ), and global sales of GLP-1 therapies topped $54 billion in 2024 ( [2] )

Carretero Gmez J, Galeano Fernndez TF, Vidal Ros AS, Prez Palacios MR, Garca Garca GM, Garca Carrasco C, et al

Herbal patches do not contain GLP-1 and should not be expected to produce GLP-1-like effects

Smokers in the study who got the semaglutide also cut back on cigarettes, noted Luba Yammine of UTHealth Houston, who is leading other research on GLP-1 drugs for people who want to quit smoking